These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33132043)

  • 1. Acquisition of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in intensive care units in Thailand.
    Assawatheptawee K; Kiddee A; Na-Udom A; Wangteeraprasert A; Treebupachatsakul P; Niumsup PR
    J Infect Chemother; 2021 Feb; 27(2):401-405. PubMed ID: 33132043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
    Pornsinchai P; Chongtrakool P; Diraphat P; Siripanichgon K; Malathum K
    Southeast Asian J Trop Med Public Health; 2015 Jan; 46(1):51-62. PubMed ID: 26513905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of extended-spectrum beta-lactamase-producing
    Siriphap A; Kitti T; Khuekankaew A; Boonlao C; Thephinlap C; Thepmalee C; Suwannasom N; Khoothiam K
    Front Cell Infect Microbiol; 2022; 12():955774. PubMed ID: 36004324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors for gastrointestinal colonization by ESBL-producing Klebsiella pneumoniae and Escherichia coli in anaesthesiology and reanimation intensive care unit].
    Oğuz Mızrakçı S; Arda B; Erdem HA; Uyar M; Tünger A; Sipahi OR; Ulusoy S
    Mikrobiyol Bul; 2013 Apr; 47(2):223-9. PubMed ID: 23621722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTX-M-15 in combination with aac(6')-Ib-cr is the most prevalent mechanism of resistance both in Escherichia coli and Klebsiella pneumoniae, including K. pneumoniae ST258, in an ICU in Uruguay.
    Bado I; Gutiérrez C; García-Fulgueiras V; Cordeiro NF; Araújo Pirez L; Seija V; Bazet C; Rieppi G; Vignoli R
    J Glob Antimicrob Resist; 2016 Sep; 6():5-9. PubMed ID: 27530831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
    Abrar S; Vajeeha A; Ul-Ain N; Riaz S
    Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli in Thai hospitals.
    Niumsup PR; Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S
    J Infect Chemother; 2008 Dec; 14(6):404-8. PubMed ID: 19089552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital.
    Kader AA; Kumar A
    Ann Saudi Med; 2005; 25(3):239-42. PubMed ID: 16119526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of community-onset extended-spectrum β-lactamase-producing
    Richelsen R; Smit J; Anru PL; Schønheyder HC; Nielsen H
    Infect Dis (Lond); 2020 Aug; 52(8):547-556. PubMed ID: 32401562
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Park SY; Kang CI; Joo EJ; Ha YE; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Microb Drug Resist; 2012 Oct; 18(5):518-24. PubMed ID: 22742454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
    Shakil S; Ali SZ; Akram M; Ali SM; Khan AU
    J Trop Pediatr; 2010 Apr; 56(2):90-6. PubMed ID: 19608665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
    Hernández JR; Pascual A; Cantón R; Martínez-Martínez L;
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):77-82. PubMed ID: 12586030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.
    Hyle EP; Lipworth AD; Zaoutis TE; Nachamkin I; Fishman NO; Bilker WB; Mao X; Lautenbach E
    Clin Infect Dis; 2005 May; 40(9):1317-24. PubMed ID: 15825035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.
    Huang Y; Zhuang S; Du M
    Infection; 2007 Oct; 35(5):339-45. PubMed ID: 17721736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
    Johnson JK; Robinson GL; Pineles LL; Ajao AO; Zhao L; Albrecht JS; Harris AD; Thom KA; Furuno JP
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes.
    Apisarnthanarak A; Kiratisin P; Mundy LM
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1026-34. PubMed ID: 18947321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole Genome Sequencing of Extended Spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae Isolated from Hospitalized Patients in KwaZulu-Natal, South Africa.
    Founou RC; Founou LL; Allam M; Ismail A; Essack SY
    Sci Rep; 2019 Apr; 9(1):6266. PubMed ID: 31000772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.